Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsYulong Gao, Mark J. Smyth, Arabella Young et al.|Nature Immunology|2017Cited by 639
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityXian-Yang Li, Mark J. Smyth, Achim K. Moesta et al.|Cancer Discovery|2019Cited by 269